Viking Global Investors
Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.
Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.
View Older Stories View More Recent Stories
-
Druva Delivers Data Protection With Built-In Disaster Recovery on AWS
-
Impossible Foods Hires Ravi Thakkar as Vice President of Product Management
-
UPDATE: Viking Global's 13F Shows New Stakes in Uber (UBER), Boeing (BA), Monster Beverage (MNST), Salesforces (CRM) (More...)
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
-
MedAnswers Raises $5 Million Seed Round and Launches First Social Media Feed with Scientifically and Clinically Validated Fertility Resources On The FertilityAnswers App
-
MedAnswers Raises $5 Million Seed Round and Launches First Social Media Feed with Scientifically and Clinically Validated Fertility Resources On The FertilityAnswers App
-
Druva and VMware Bring Data Protection for the Cloud Era to VMworld 2019
-
CORRECTING and REPLACING Druva and VMware Bring Data Protection for the Cloud Era to VMworld 2019
-
Druva Expands Executive Team as Company Continues Phase of Hypergrowth
-
Sodexo Launches New Impossible™ Burger Menu at more than 1,500 U.S. Locations
-
Hedge fund Hoplite Capital plans to shut down - letter
-
BURGER KING® Restaurants Launches the Impossible™ WHOPPER® Nationwide
-
Impossible Foods Receives Approval for Its Color Additive Petition From US Food and Drug Administration
-
Impossible Foods Launches Co-manufacturing Collaboration With OSI
-
Druva Appoints Bill Losch, Okta CFO, to Board of Directors
-
Druva Set to Bring Cloud to the Edge with CloudLanes Acquisition
-
Form SC 13D/A Axovant Gene Therapies Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Arbutus Biopharma Corp For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Arbutus Biopharma Corp For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Axovant Gene Therapies For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Axovant Gene Therapies For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Myovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Myovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Urovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Form 4 Urovant Sciences Ltd. For: Jul 10 Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Myovant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Arbutus Biopharma Corp Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D/A Urovant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
-
Form SC 13D BridgeBio Pharma, Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Druva Gives Channel Partners the Keys to Cloud with Druva Compass
-
Kids in the Kitchen: Impossible Foods Releases Research on Plant Based Food Consumption Amongst Millennials and Gen Z
-
Form 3 Adaptive Biotechnologies For: Jun 26 Filed by: Viking Global Equities LP
-
Hercules Capital Announces Multiple Portfolio Company Achievements in Q2 2019
-
Druva Adds Nick Turner as VP of EMEA to Lead Regional Sales Organisation
-
Druva Raises $130 Million to Power Data Protection for the Cloud Era
-
Viela Bio Closes $75 Million Series B Financing
-
Form SC 13D Myovant Sciences Ltd. Filed by: VIKING GLOBAL INVESTORS LP
-
Motif Ingredients Appoints Michele Fite as Chief Commercial Officer
-
Druva Founder and CEO Jaspreet Singh Selected as Finalist for EY Entrepreneur Of The Year® 2019 Award in Northern California
-
Impossible Foods Releases 2019 Impact Report, Asking, “If Not Us, Then Who?”
-
Synlogic (SYBX) Announces Collaboration with Ginkgo Bioworks to Accelerate Development of Novel Synthetic Biotic Medicines
-
Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines
-
Dan Loeb's Third Point Bets on Humana (HUM) 'Bear Hug' for Centene (CNC) - Sources
-
Form 4 Urovant Sciences Ltd. For: May 21 Filed by: Viking Global Opportunities Illiquid Investments Sub-Master LP
-
Inhibrx Announces $40M Investment from Viking Global Investors
-
Form 4 Urovant Sciences Ltd. For: May 16 Filed by: VIKING GLOBAL INVESTORS LP
-
Form 4 Urovant Sciences Ltd. For: May 16 Filed by: VIKING GLOBAL PERFORMANCE LLC
-
Viking Global's 13F Shows New Stakes in Activision Blizzard (ATVI), Allstate (ALL), JD.com (JD), Micron (MU) (More...)
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
-
BURGER KING® Restaurants Introduces the Plant-Based Impossible™ WHOPPER® in Three New Markets

